JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8
JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8
JoneStrading啓動對Purple Biotech的報道，評級爲買入，宣佈目標股價爲8美元
JonesTrading analyst Catherine Novack initiates coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and announces Price Target of $8.
JoneStrading分析師凱瑟琳·諾瓦克開始對Purple Biotech（納斯達克股票代碼：PPBT）進行報道，評級爲買入，並宣佈目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。